US Life Sciences Investment Dips But Main Hubs Dodge Headwinds: Report

October 10, 2022

Article by:  Anna Staropoli

Venture capital funding dropped 18.5 percent this year and now hovers at $20.8 billion after the first half of 2022, Newmark says. Despite the short-term decline, this number remains higher than every full year prior to 2018.

Read the full article: